ICAD Deficiency in Human Colon Cancer and Predisposition to Colon Tumorigenesis: Linkage to Apoptosis Resistance and Genomic Instability

Errami, Youssef; Brim, Hassan; Oumouna-Benachour, Karine; Oumouna, Mustapha; Naura, Amarjit S.; Kim, Hogyoung; Ju, Jihang; Davis, Christian J.; Kim, Jong G.; Ashktorab, Hassan; Fallon, Kenneth; Xu, Ming; Zhang, Jianhua; Valle, Luis Del; Boulares, A. Hamid
February 2013
PLoS ONE;Feb2013, Vol. 8 Issue 2, p1
Academic Journal
We previously showed that DNA fragmentation factor, which comprises a caspase-3-activated DNase (CAD) and its inhibitor (ICAD), may influence the rate of cell death by generating PARP-1-activating DNA breaks. Here we tested the hypothesis that ICAD-deficient colon epithelial cells exhibiting resistance to death stimuli may accumulate additional genetic modifications, leading to a tumorigenic phenotype. We show that ICAD deficiency may be associated with colon malignancy in humans. Indeed, an examination of ICAD expression using immunohistochemistry in an array of both colon cancer and normal tissues revealed that ICAD expression levels were severely compromised in the cancerous tissues. Upon DNA damage caused by a low dose of irradiation, ICAD cells acquire a tumorigenic phenotype. Colon epithelial cells derived from ICAD mice showed a significant resistance to death induced by the colon carcinogen dimethylhydrazine in vitro and in mice. Such resistance was associated with a decrease in PARP-1 activation. In an animal model of dimethylhydrazine-induced colon tumorigenesis, ICAD−/− mice developed significantly higher numbers of tumors with markedly larger sizes than the wild-type counterparts. Interestingly, the phenotype of the ICAD−/− mice was not associated with a significant increase in the precancerous aberrant crypt foci suggesting a potential link to tumor progression rather than initiation. More importantly, ICAD deficiency was associated with severe genomic instability as assessed by array comparative genomic hybridization. Such genomic instability consisted most prominently of amplifications but with sizable deletions as compared to the wild-type counterparts affecting several cancer-related genes including RAF-1, GSN, LMO3, and Fzd6 independently of p53. Altogether, our results present a viable case for the involvement of ICAD deficiency in colon carcinogenesis and show that apoptosis and genomic instability may comprise the means by which such deficiency may contribute to the process of increasing susceptibility to carcinogen-induced tumorigenesis.


Related Articles

  • Aberrantly regulated dysadherin and B-cell lymphoma 2/B-cell lymphoma 2-associated X enhances tumorigenesis and DNA targeting drug resistance of liver cancer stem cells. NAN JIANG; WEI CHEN; JIAN-WEN ZHANG; YANG LI; XIAN-CHENG ZENG; TONG ZHANG; BIN-SHENG FU; HUI-MIN YI; QI ZHANG // Molecular Medicine Reports;2015, Vol. 12 Issue 5, p7239 

    Cancer stem cells (CSCs) in hepatocellular carcinoma (HCC) are frequently resistant to current therapeutic regimens and therefore responsible for tumor recurrence. Previous studies have reported that expression levels of dysadherin in CSCs may be used as a prognostic indicator, which is also...

  • Overexpression of MicroRNA-122 Re-sensitizes 5-FU-Resistant Colon Cancer Cells to 5-FU Through the Inhibition of PKM2 In Vitro and In Vivo. He, Jinxia; Xie, Ganfeng; Tong, Jingtao; Peng, Yonghai; Huang, Haihui; Li, Jianjun; Wang, Ning; Liang, Houjie // Cell Biochemistry & Biophysics;Nov2014, Vol. 70 Issue 2, p1343 

    5-Fluorouracil (5-FU) is one of the most commonly used anticancer drugs in the treatment of colon cancer. However, acquired chemoresistance is becoming one of the major challenges for patients with advanced stages of colon cancer. Currently, the mechanisms underlying cancer cell resistance to...

  • Cancer stem cells: emerging actors in both basic and clinical cancer research. KARAKAŞ, Didem; CEVATEMRE, Buse; ULUKAYA, Engin // Turkish Journal of Biology;2014, Vol. 38 Issue 6, p829 

    Cancer stem cells (CSCs) are a small subset of cancer cells within a tumor that are responsible for tumorigenesis and contribute to drug resistance. The CSC displays an anchorage-independent survival, active DNA-repair capacity, and relative quiescence and is capable of self-renewing and...

  • Precritical State Transition Dynamics in the Attractor Landscape of a Molecular Interaction Network Underlying Colorectal Tumorigenesis. Chu, Hyunho; Lee, Daewon; Cho, Kwang-Hyun // PLoS ONE;10/6/2015, Vol. 10 Issue 10, p1 

    From the perspective of systems science, tumorigenesis can be hypothesized as a critical transition (an abrupt shift from one state to another) between proliferative and apoptotic attractors on the state space of a molecular interaction network, for which an attractor is defined as a stable...

  • EGFR-Targeted TRAIL and a Smac Mimetic Synergize to Overcome Apoptosis Resistance in KRAS Mutant Colorectal Cancer Cells. Möller, Yvonne; Siegemund, Martin; Beyes, Sven; Herr, Ricarda; Lecis, Daniele; Delia, Domenico; Kontermann, Roland; Brummer, Tilman; Pfizenmaier, Klaus; Olayioye, Monilola A. // PLoS ONE;Sep2014, Vol. 9 Issue 9, p1 

    TRAIL is a death receptor ligand that induces cell death preferentially in tumor cells. Recombinant soluble TRAIL, however, performs poorly as an anti-cancer therapeutic because oligomerization is required for potent biological activity. We previously generated a diabody format of tumor-targeted...

  • Putative cis-regulatory drivers in colorectal cancer. Ongen, Halit; Andersen, Claus L.; Bramsen, Jesper B.; Oster, Bodil; Rasmussen, Mads H.; Ferreira, Pedro G.; Sandoval, Juan; Vidal, Enrique; Whiffin, Nicola; Planchon, Alexandra; Padioleau, Ismael; Bielser, Deborah; Romano, Luciana; Tomlinson, Ian; Houlston, Richard S.; Esteller, Manel; Orntoft, Torben F.; Dermitzakis, Emmanouil T. // Nature;8/6/2014, Vol. 512 Issue 7512, p87 

    The cis-regulatory effects responsible for cancer development have not been as extensively studied as the perturbations of the protein coding genome in tumorigenesis. To better characterize colorectal cancer (CRC) development we conducted an RNA-sequencing experiment of 103 matched tumour and...

  • DNA methylation as an epigenetic biomarker in colorectal cancer. DONIZETTI SILVA, TIAGO; MARQUES VIDIGAL, VERONICA; VITOR FELIPE, ALEDSON; MIRANDA DE LIMA, JACQUELINE; ARTIGIANI NETO, RICARDO; SIDNEY SAAD, SARHAN; MANOUKIAN FORONES, NORA // Oncology Letters;2013, Vol. 6 Issue 6, p1687 

    Sporadic colorectal cancer (CRC) is a consequence of the accumulation of genetic and epigenetic alterations that result in the transformation of normal colonic epithelial cells to adenocarcinomas. Studies have indicated that a common event in the tumorigenesis of CRC is the association of global...

  • MicroRNA-218 is a prognostic indicator in colorectal cancer and enhances 5-fluorouracil-induced apoptosis by targeting BIRC5. Pei-Long Li; Xin Zhang; Li-Li Wang; Lu-Tao Du; Yong-Mei Yang; Juan Li; Chuan-Xin Wang // Carcinogenesis;Dec2015, Vol. 36 Issue 12, p1484 

    One major reason for the failure of advanced colorectal cancer (CRC) treatment is the occurrence of chemoresistance to fluoropyrimidine (FU)-based chemotherapy. Various reports showed that ectopic expression and function of microRNAs (miRNAs) played key roles to mediate apoptosis at the...

  • Epieriocalyxin A Induces Cell Apoptosis Through JNK and ERK1/2 Signaling Pathways in Colon Cancer Cells. Wang, Zhou; Xu, Zhijie; Niu, Zhengchuan; Liang, Benjia; Niu, Jun // Cell Biochemistry & Biophysics;Nov2015, Vol. 73 Issue 2, p559 

    Colorectal cancer is one of the most commonly diagnosed cancers in the world. Currently, drug resistance of cancer cell to chemotherapy is a major cause for cancer recurrence and death of the patients; therefore, new therapeutic strategy is required to improve the care of colorectal cancer...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics